engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of ...

Dr Matthew Kent at the Norwegian University of Life Sciences (NMBU) leads a new project to improve disease resistance in ...

The Genome Editing Market is expected to grow significantly due to advancements in gene therapy technologies and the increasing demand for genetically modified organisms (GMOs) in agriculture and ...

2 Another highlighted Cerba Research’s unbiased sequencing approach accurately identifies vector integration sites using ...

We can already tinker with human DNA to treat diseases. But being able to edit RNA allows for even more precision – and fewer ...

Researchers have used whole-genome CRISPR interference screening to identify the “Achilles Heel” of drug-resistant ...

A new type of therapy that 'edits' a gene in patients with a rare heart condition has been shown to be safe and effective, according to research from UCL and the Royal Free Hospital.

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report). The ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...